In this brief summary, we argue that many widely held beliefs about HLA-G a
re questionable. Recent research has led to a re-evaluation of many of the
characteristics that were thought to make HLA-G unusual among the MHC class
I molecules. First, contrary to reports suggesting that the gene encoding
HLA-G exhibits marked polymorphism in some human populations, recent data h
ave shown that the HLA-G gene has comparatively little polymorphism-a featu
re that might allow it to be expressed in the placenta without causing reje
ction by the maternal immune system. Second, although truncated forms of HL
A-G are generated in the placenta, most of them are unlikely to have signif
icant biological effects as they do not reach the cell surface. Third, the
hypothesis that a major role of HLA-G is to prevent attack of the placenta
by maternal natural killer cells is now the subject of renewed scrutiny. Fi
nally, there is little evidence that the induction of expression of HLA-G i
s a major mechanism by which tumor cells avoid immune attack. HLA-G has onc
e again become as mysterious as when it was discovered: an MHC class I mole
cule expressed at a challengingly extraordinary site-the immunologically un
easy interface between mother and fetus.